Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity


Autoria(s): OLIVEIRA, Maura S.; PRADO, Gladys V. B.; COSTA, Silvia F.; GRINBAUM, Renato S.; LEVIN, Anna S.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

We compared 41 patients who received colistimethate with 41 who received polymyxin B for the treatment of serious infections caused by carbapenem-resistant Acinetobacter spp. and found both polymyxins have similar efficacy and toxicity. (C) 2009 Elsevier Inc. All rights reserved.

Identificador

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, v.65, n.4, p.431-434, 2009

0732-8893

http://producao.usp.br/handle/BDPI/22159

10.1016/j.diagmicrobio.2009.07.018

http://dx.doi.org/10.1016/j.diagmicrobio.2009.07.018

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

Relação

Diagnostic Microbiology and Infectious Disease

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #Polymyxins #Antibiotics #Drug resistance #INFECTIONS #ACINETOBACTER #COLISTIN #Infectious Diseases #Microbiology
Tipo

article

original article

publishedVersion